The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Open accessAbstract
Importance: Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes. Objective: To compare clinical characteristics and outcomes of children and adolescents with MIS-C vs those with severe coronavirus disease 2019 (COVID-19). Setting, Design, and Participants: Case series of 1116 patients aged younger than 21 years hospitalized between March 15 and October 31, 2020, at 66 US hospitals in 31 states. Final date of follow-up was January 5, 2021. Patients with MIS-C had fever, inflammation, multisystem involvement, and positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase-polymerase chain reaction (RT-PCR) or antibody test results or recent exposure with no alternate diagnosis. Patients with COVID-19 had positive RT-PCR test results and severe organ system involvement. Exposure: SARS-CoV-2. Main Outcomes and Measures: Presenting symptoms, organ system complications, laboratory biomarkers, interventions, and clinical outcomes. Multivariable regression was used to compute adjusted risk ratios (aRRs) of factors associated with MIS-C vs COVID-19. Results: Of 1116 patients (median age, 9.7 years; 45% female), 539 (48%) were diagnosed with MIS-C and 577 (52%) with COVID-19. Compared with patients with COVID-19, patients with MIS-C were more likely to be 6 to 12 years old (40.8% vs 19.4%; absolute risk difference [RD], 21.4% [95% CI, 16.1%-26.7%]; aRR, 1.51 [95% CI, 1.33-1.72] vs 0-5 years) and non-Hispanic Black (32.3% vs 21.5%; RD, 10.8% [95% CI, 5.6%-16.0%]; aRR, 1.43 [95% CI, 1.17-1.76] vs White). Compared with patients with COVID-19, patients with MIS-C were more likely to have cardiorespiratory involvement (56.0% vs 8.8%; RD, 47.2% [95% CI, 42.4%-52.0%]; aRR, 2.99 [95% CI, 2.55-3.50] vs respiratory involvement), cardiovascular without respiratory involvement (10.6% vs 2.9%; RD, 7.7% [95% CI, 4.7%-10.6%]; aRR, 2.49 [95% CI, 2.05-3.02] vs respiratory involvement), and mucocutaneous without cardiorespiratory involvement (7.1% vs 2.3%; RD, 4.8% [95% CI, 2.3%-7.3%]; aRR, 2.29 [95% CI, 1.84-2.85] vs respiratory involvement). Patients with MIS-C had higher neutrophil to lymphocyte ratio (median, 6.4 vs 2.7, P < .001), higher C-reactive protein level (median, 152 mg/L vs 33 mg/L; P < .001), and lower platelet count (<150 ×103 cells/μL [212/523 {41%} vs 84/486 {17%}, P < .001]). A total of 398 patients (73.8%) with MIS-C and 253 (43.8%) with COVID-19 were admitted to the intensive care unit, and 10 (1.9%) with MIS-C and 8 (1.4%) with COVID-19 died during hospitalization. Among patients with MIS-C with reduced left ventricular systolic function (172/503, 34.2%) and coronary artery aneurysm (57/424, 13.4%), an estimated 91.0% (95% CI, 86.0%-94.7%) and 79.1% (95% CI, 67.1%-89.1%), respectively, normalized within 30 days. Conclusions and Relevance: This case series of patients with MIS-C and with COVID-19 identified patterns of clinical presentation and organ system involvement. These patterns may help differentiate between MIS-C and COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., Baker, A. L., Jackson, M. A., Takahashi, M., Shah, P. B., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000484 · Cited by 3,723
Self-citationMultisystem Inflammatory Syndrome in U.S. Children and Adolescents
Feldstein, L. R., Rose, E. B., Horwitz, S. M., Collins, J. P., Newhams, M. M., Son, M. B. F., Newburger, J. W., Kleinman, L. C., Heidemann, S. M., Martin, A. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021680 · Cited by 2,643
Self-citationHyperinflammatory shock in children during COVID-19 pandemic
Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N., & Theocharis, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31094-1 · Cited by 2,494
SARS-CoV-2 Infection in Children
Lu, X., Zhang, L., Du, H., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,431
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomi, E., & D'Antiga, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31103-x · Cited by 2,380
Easy SAS Calculations for Risk or Prevalence Ratios and Differences
Spiegelman, D. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi188 · Cited by 1,738
Lopez, L., Colan, S. D., Frommelt, P. C., Ensing, G. J., Kendall, K., Younoszai, A. K., Lai, W. W., & Geva, T. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.03.019 · Cited by 1,553
Multisystem Inflammatory Syndrome in Children in New York State
Dufort, E. M., Koumans, E. H., Chow, E. J., Rosenthal, E. M., Muse, A., Rowlands, J., Barranco, M. A., Maxted, A. M., Rosenberg, E. S., Easton, D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021756 · Cited by 1,350
Self-citationCOVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
Götzinger, F., Santiago-García, B., Noguera-Julián, A., Lanaspa, M., Lancella, L., Calò Carducci, F. I., Gabrovska, N., Velizarova, S., Prunk, P., Osterman, V., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30177-2 · Cited by 1,219
Belhadjer, Z., Méot, M., Bajolle, F., Khraiche, D., Legendre, A., Abakka, S., Auriau, J., Grimaud, M., Oualha, M., Beghetti, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048360 · Cited by 1,129
Castagnoli, R., Votto, M., Licari, A., Brambilla, I., Bruno, R., Perlini, S., Rovida, F., Baldanti, F., & Marseglia, G. L. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.1467 · Cited by 1,085
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020
Godfred-Cato, S., Bryant, B., Leung, J., Oster, M. E., Conklin, L., Abrams, J., Roguski, K., Wallace, B., Prezzato, E., Koumans, E. H., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6932e2 · Cited by 769
Matics, T. J., & Sanchez-Pinto, L. N. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.2352 · Cited by 664
Swann, O. V., Holden, K. A., Turtle, L., Pollock, L., Fairfield, C. J., Drake, T. M., Seth, S., Egan, C., Hardwick, H. E., Halpin, S., et al. (2020) · BMJ · doi:10.1136/bmj.m3249 · Cited by 643
Henderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Ferris, A., Kernan, K. F., Schulert, G. S., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41454 · Cited by 531
Self-citationElectronic Code of Federal Regulations
(2018) · Cited by 491
Henderson, L. A., Canna, S. W., Friedman, K. G., Gorelik, M., Lapidus, S. K., Bassiri, H., Behrens, E. M., Ferris, A., Kernan, K. F., Schulert, G. S., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41616 · Cited by 412
Self-citationLee, P. Y., Day-Lewis, M., Henderson, L. A., Friedman, K. G., Lo, J., Roberts, J. E., Lo, M. S., Platt, C. D., Chou, J., Hoyt, K. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141113 · Cited by 396
Self-citationSperotto, F., Friedman, K. G., Son, M. B. F., VanderPluym, C. J., Newburger, J. W., & Dionne, A. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-020-03766-6 · Cited by 385
Self-citationUnderstanding SARS-CoV-2-related multisystem inflammatory syndrome in children
Rowley, A. H. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0367-5 · Cited by 377
Valverde, I., Singh, Y., Sanchez-de-Toledo, J., Theocharis, P., Chikermane, A., Di Filippo, S., Kuciñska, B., Mannarino, S., Tamariz-Martel, A., Gutierrez-Larraya, F., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050065 · Cited by 349
Computing Adjusted Risk Ratios and Risk Differences in Stata
Norton, E. C., Miller, M. M., & Kleinman, L. C. (2013) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1301300304 · Cited by 300
Matsubara, D., Kauffman, H. L., Wang, Y., Calderon-Anyosa, R., Nadaraj, S., Elias, M. D., White, T. J., Torowicz, D. L., Yubbu, P., Giglia, T. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.056 · Cited by 251
Kawasaki disease: insights into pathogenesis and approaches to treatment
Shulman, S. T., & Rowley, A. H. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.54 · Cited by 221
Fernandes, D. M., Oliveira, C. R., Guerguis, S., Eisenberg, R., Choi, J., Kim, M., Abdelhemid, A., Agha, R., Agarwal, S., Aschner, J. L., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.11.016 · Cited by 205
Self-citationTheocharis, P., Wong, J., Pushparajah, K., Mathur, S., Simpson, J. M., Pascall, E., Cleary, A., Stewart, K., Adhvaryu, K., Savis, A., et al. (2020) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaa212 · Cited by 149
Belhadjer, Z., Auriau, J., Méot, M., Oualha, M., Renolleau, S., Houyel, L., & Bonnet, D. (2020) · Circulation · doi:10.1161/circulationaha.120.050147 · Cited by 101
Daily estimation of the severity of multiple organ dysfunction syndrome in critically ill children
Leteurtre, S., Duhamel, A., Grandbastien, B., Proulx, F., Cotting, J., Gottesman, R. D., Joffe, A. R., Wagner, B., Hubert, P., Martinot, A., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.081715 · Cited by 100
Coronary Artery Dimensions in Febrile Children Without Kawasaki Disease
Muniz, J. C., Dummer, K., Gauvreau, K., Colan, S. D., Fulton, D. R., & Newburger, J. W. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.000159 · Cited by 95
Self-citationCOVID-19 and Heart Failure With Preserved Ejection Fraction
Freaney, P. M., Shah, S. J., & Khan, S. S. (2020) · JAMA · doi:10.1001/jama.2020.17445 · Cited by 95
Cited by
Myocarditis With COVID-19 mRNA Vaccines
Bozkurt, B., Kamat, I., & Hotez, P. J. (2021) · Circulation · doi:10.1161/circulationaha.121.056135 · Cited by 806
Long-term complications of COVID-19
Desai, A. D., Lavelle, M., Boursiquot, B. C., & Wan, E. Y. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00375.2021 · Cited by 415
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
Son, M. B. F., Murray, N., Friedman, K., Young, C. C., Newhams, M. M., Feldstein, L. R., Loftis, L. L., Tarquinio, K. M., Singh, A. R., Heidemann, S. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102605 · Cited by 366
Self-citationTreatment of Multisystem Inflammatory Syndrome in Children
McArdle, A. J., Vito, O., Patel, H., Seaby, E. G., Shah, P., Wilson, C., Broderick, C., Nijman, R., Tremoulet, A. H., Munblit, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102968 · Cited by 352
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Lipsitch, M., Krammer, F., Regev-Yochay, G., Lustig, Y., & Balicer, R. D. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00662-4 · Cited by 336
Metadata
- Authors
- Feldstein, L. R., Tenforde, M. W., Friedman, K. G., Newhams, M., Rose, E. B., Dapul, H., Soma, V. L., Maddux, A. B., Mourani, P. M., Bowens, C., Maamari, M., Hall, M. W., Riggs, B. J., Giuliano, J. S., Singh, A. R., Li, S., Kong, M., Schuster, J. E., McLaughlin, G. E., Schwartz, S. P., Walker, T. C., Loftis, L. L., Hobbs, C. V., Halasa, N. B., Doymaz, S., Babbitt, C. J., Hume, J. R., Gertz, S. J., Irby, K., Clouser, K. N., Cvijanovich, N. Z., Bradford, T. T., Smith, L. S., Heidemann, S. M., Zackai, S. P., Wellnitz, K., Nofziger, R. A., Horwitz, S. M., Carroll, R. W., Rowan, C. M., Tarquinio, K. M., Mack, E. H., Fitzgerald, J. C., Coates, B. M., Jackson, A. M., Young, C. C., Son, M. B. F., Patel, M. M., Newburger, J. W., Randolph, A. G., & Overcoming COVID-19 Investigators
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-03-16
- Volume
- 325
- Issue
- 11
- Pages
- 1074
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3132267494
- Cited by
- 817
- References
- 32
- FWCI
- 154.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.